BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 38646633)

  • 1. Overview of
    Chakkour M; Hammoud Z; Farhat S; El Roz A; Ezzeddine Z; Ghssein G
    Front Microbiol; 2024; 15():1383618. PubMed ID: 38646633
    [No Abstract]   [Full Text] [Related]  

  • 2. Into the understanding the multicellular lifestyle of
    Gmiter D; Kaca W
    Front Cell Infect Microbiol; 2022; 12():864305. PubMed ID: 36118021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virulence genes and antimicrobial resistance pattern in Proteus mirabilis strains isolated from patients attended with urinary infections to Tertiary Hospitals, in Iran.
    Tabatabaei A; Ahmadi K; Shabestari AN; Khosravi N; Badamchi A
    Afr Health Sci; 2021 Dec; 21(4):1677-1684. PubMed ID: 35283944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of resistance and virulence characteristics of clinical multidrug-resistant
    Li Y; Yin M; Fang C; Fu Y; Dai X; Zeng W; Zhang L
    Front Cell Infect Microbiol; 2023; 13():1229194. PubMed ID: 37637463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteus mirabilis and Urinary Tract Infections.
    Schaffer JN; Pearson MM
    Microbiol Spectr; 2015 Oct; 3(5):. PubMed ID: 26542036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virulence targeted inhibitory effect of linalool against the exclusive uropathogen
    Durgadevi R; Veera Ravi A; Alexpandi R; Krishnan Swetha T; Abirami G; Vishnu S; Karutha Pandian S
    Biofouling; 2019 May; 35(5):508-525. PubMed ID: 31144520
    [No Abstract]   [Full Text] [Related]  

  • 7.
    Wasfi R; Hamed SM; Amer MA; Fahmy LI
    Front Cell Infect Microbiol; 2020; 10():414. PubMed ID: 32923408
    [No Abstract]   [Full Text] [Related]  

  • 8. Biofilm Formation and Immunomodulatory Activity of Proteus mirabilis Clinically Isolated Strains.
    Fusco A; Coretti L; Savio V; Buommino E; Lembo F; Donnarumma G
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of polyphosphate kinase in virulence and stress tolerance of uropathogenic Proteus mirabilis.
    Peng L; Jiang Q; Pan JY; Deng C; Yu JY; Wu XM; Huang SH; Deng XY
    Med Microbiol Immunol; 2016 Apr; 205(2):97-109. PubMed ID: 26233310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin inhibits swarming motility and activates biofilm production of Proteus mirabilis possibly by interacting with central regulators, metabolic status or active pump proteins.
    Aygül A; Öztürk İ; Çilli FF; Ermertcan Ş
    Phytomedicine; 2019 Apr; 57():65-71. PubMed ID: 30668324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteus mirabilis Overview.
    Mobley HLT
    Methods Mol Biol; 2019; 2021():1-4. PubMed ID: 31309490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indole Derivatives Obtained from Egyptian
    Amer MA; Wasfi R; Attia AS; Ramadan MA
    Antibiotics (Basel); 2021 Mar; 10(4):. PubMed ID: 33805493
    [No Abstract]   [Full Text] [Related]  

  • 13. Cranberry derivatives enhance biofilm formation and transiently impair swarming motility of the uropathogen Proteus mirabilis HI4320.
    O'May C; Amzallag O; Bechir K; Tufenkji N
    Can J Microbiol; 2016 Jun; 62(6):464-74. PubMed ID: 27090825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Antibiotic-Susceptibility Patterns, Virulence Factor Profiles and Clonal Relatedness in
    Mirzaei A; Habibi M; Bouzari S; Asadi Karam MR
    Infect Drug Resist; 2019; 12():3967-3979. PubMed ID: 31920349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Explication of the Potential of 2-Hydroxy-4-Methoxybenzaldehyde in Hampering Uropathogenic
    Durgadevi R; Abirami G; Alexpandi R; Nandhini K; Kumar P; Prakash S; Veera Ravi A
    Front Microbiol; 2019; 10():2804. PubMed ID: 31921010
    [No Abstract]   [Full Text] [Related]  

  • 16. A Phage Cocktail To Control Surface Colonization by Proteus mirabilis in Catheter-Associated Urinary Tract Infections.
    Mirzaei A; Wagemans J; Nasr Esfahani B; Lavigne R; Moghim S
    Microbiol Spectr; 2022 Oct; 10(5):e0209222. PubMed ID: 36194151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of Proteus mirabilis in Catheter-Associated Urinary Tract Infections.
    Yuan F; Huang Z; Yang T; Wang G; Li P; Yang B; Li J
    Urol Int; 2021; 105(5-6):354-361. PubMed ID: 33691318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of
    Armbruster CE; Mobley HLT; Pearson MM
    EcoSal Plus; 2018 Feb; 8(1):. PubMed ID: 29424333
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenic Factors Correlate With Antimicrobial Resistance Among Clinical
    Filipiak A; Chrapek M; Literacka E; Wawszczak M; Głuszek S; Majchrzak M; Wróbel G; Łysek-Gładysińska M; Gniadkowski M; Adamus-Białek W
    Front Microbiol; 2020; 11():579389. PubMed ID: 33324365
    [No Abstract]   [Full Text] [Related]  

  • 20. Proteus mirabilis isolates of different origins do not show correlation with virulence attributes and can colonize the urinary tract of mice.
    Sosa V; Schlapp G; Zunino P
    Microbiology (Reading); 2006 Jul; 152(Pt 7):2149-2157. PubMed ID: 16804188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.